Cellular Fibronectin in Serum and Plasma: A Potential New Tumour Marker?

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1995.112
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Serum Lipids and Apolipoprotein Concentrations and Plasma Fibronectin Concentrations in Renal Transplant Patients

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
1992English

Serum Anti-P53 Antibody as a Tumour Marker for Colorectal Cancer Screening

ecancermedicalscience
Cancer ResearchOncology
2015English

Unique Cyanide Adduct in Human Serum Albumin: Potential as a Surrogate Exposure Marker

Chemical Research in Toxicology
MedicineToxicology
2011English

Plasma Epstein-Barr Virus DNA as an Archetypal Circulating Tumour DNA Marker

Journal of Pathology
Forensic MedicinePathology
2019English

Cathepsin D Is a Potential Serum Marker for Poor Prognosis in Glioma Patients

Cancer Research
Cancer ResearchOncology
2005English

Serum Anti-Eif3a Autoantibody as a Potential Diagnostic Marker for Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2019English

Frequency of Serum Tumour Marker Monitoring in Patients With Non-Seminomatous Germ Cell Tumours

British Journal of Cancer
Cancer ResearchOncology
1990English

Serum MMP-2 as a Potential Predictive Marker for Papillary Thyroid Carcinoma

PLoS ONE
Multidisciplinary
2018English

Serum Bone Sialoprotein as a Marker of Tumour Burden and Neoplastic Bone Involvement and as a Prognostic Factor in Multiple Myeloma

British Journal of Cancer
Cancer ResearchOncology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy